# ELAHERE
> **BLA761310** · Biologics License Application · Sponsor: IMMUNOGEN INC · Approved 2022-11-14
## Drug
- **FDA Application Number:** BLA761310
- **Application type:** Biologics License Application
- **Brand name:** ELAHERE
- **Generic name:** MIRVETUXIMAB SORAVTANSINE
- **Active ingredients:** MIRVETUXIMAB SORAVTANSINE-GYNX
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** IMMUNOGEN INC
- **Manufacturer:** ImmunoGen, Inc.
- **First approval:** 2022-11-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761310)
---
*MORVS · CC0 1.0*